عربي English Türkçe اردو فارسى
Logo
Latest News
Varieties

National Center for Wildlife Releases 85 Wild Animals into Royal Reserve of Prince Mohammed bin Salman

The release program primarily focuses on reintroducing endangered indigenous species to their natural habitats. (SPA)
The release program primarily focuses on reintroducing endangered indigenous species to their natural habitats. (SPA)
TT
TT

National Center for Wildlife Releases 85 Wild Animals into Royal Reserve of Prince Mohammed bin Salman

The release program primarily focuses on reintroducing endangered indigenous species to their natural habitats. (SPA)
The release program primarily focuses on reintroducing endangered indigenous species to their natural habitats. (SPA)

The National Center for Wildlife, in cooperation with the Prince Mohammed bin Salman Royal Reserve, on Sunday released 85 endangered animals, the first batch in the 2023-2024 season, SPA said.
The release is part of the center's program concerned with increasing and relocating endangered wild animals, restructuring ecosystems, and enriching the biodiversity in the Kingdom of Saudi Arabia.
The animals released this morning are 20 Arabian oryx, 40 rim antelopes, six mountain gazelles, six alpine ibexes, and a number of birds rehabilitated in the shelter unit, comprising: four steppe eagles, four griffon vultures, one lappet-faced vulture, and four pharaoh eagle-owls.
The release was made possible by the many cooperation programs between the reserve and the center to rehabilitate the reserve's ecosystems, enrich biodiversity and achieve national targets.
National Center for Wildlife CEO Dr. Muhammed Qurban said the release program aims mainly at returning endangered indigenous species to their natural habitats.
This is one of the programs of the Saudi Green Initiative, carried out in the implementation of the National Environment Strategy in order to achieve sustainable development, wildlife growth and biodiversity, in line with global environmental conservation efforts.
It is also a step that underlines the depth of cooperation between the center and national stakeholders with mutual interest.
Qurban added that the center owns facilities specializing in the reproduction and localization of endangered organisms in their natural habitats, as per the most accurate global standards; it carries out research on their living conditions, follows up and monitors biodiversity in protected areas using modern techniques to track wildlife group, collects data and understands the risks incurred by wildlife.

Most Viewed

 
 
Varieties

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”